Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Proof of Concept Trial of a Sirtuin-NAD Activator in Alzheimer's Disease

NCT05040321 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT05040321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05040321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Proof of Concept Trial of a Sirtuin-NAD Activator in Alzheimer's Disease
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
December 1, 2021
Completion date
April 30, 2026
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease (incl subtypes), dementia